Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1372058 | Bioorganic & Medicinal Chemistry Letters | 2010 | 4 Pages |
Abstract
We substituted a truncated neuropeptide Y (NPY) analog, [Pro30, Tyr32, Leu34]NPY(28-36)NH2 also called BVD15, at various positions with DOTA (1,4,7,10-tetraazacyclododecane-1,4,7-10-tetraacetic acid) and evaluated the effect of the coupling position with the binding affinity for NPY Y1 receptors (NPY1R). Our data suggest that [Lys(DOTA)4]BVD15 (Ki = 63 ± 25 nM vs. Ki = 39 ± 34 nM for BVD15) is a potent NPY analog suitable for radiolabeling with metallo positron emitters for PET imaging of breast cancer.
Graphical abstract[Lys(DOTA)4]BVD15, a potent NPY Y1 analog suitable for radiolabeling with metallo positron emitters for PET imaging of breast cancer.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Brigitte Guérin, Véronique Dumulon-Perreault, Marie-Claude Tremblay, Samia Ait-Mohand, Patrick Fournier, Céléna Dubuc, Simon Authier, François Bénard,